Mab-338

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameMab-338

Drug Alias NameF membrane fusion protein-targeted monoclonal antibody (MedImmune)hMPV MAbF membrane fusion protein-targeted monoclonal antibody (ViroNovative BV)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human

Mechanisms of ActionEnvelope glycoprotein inhibitors

TargetsEnvelope glycoprotein

Therapy Area/IndicationsMetapneumovirus infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesViroNovative BV

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMedimmune Llc

Active IndicationsN/A

Inactive IndicationsMetapneumovirus infections

Other Information

ATC CodeN/A